NCT06777316 · Interventional trial
A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors
Overall registry status Active not recruiting
Phase 1 · Phase 2
Conditions Advanced Solid Tumors, Cholangiocarcinoma, FGFR2 Gene Amplification, FGFR2 Gene Fusion/Rearrangement, FGFR2 Gene Short Variants, FGFR2 Genetic Alterations, FGFR3 Gene Amplification, FGFR3 Gene Fusion/Rearrangement, FGFR3 Gene Short Variants, FGFR3 Genetic Alterations, Intrahepatic Cholangiocarcinoma (Icc), Other Solid Tumors, Adult
Delaware Valley sites
- Fox Chase cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory